Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Love hormone may help schizophrenia patients in therapy

NCT ID NCT06136390

First seen Dec 04, 2025 · Last updated May 23, 2026 · Updated 22 times

Summary

This study tested whether giving oxytocin (a natural hormone) as a nasal spray before group therapy helps reduce negative symptoms like social withdrawal and lack of motivation in people with schizophrenia. 42 adults took part in a triple-blind, placebo-controlled trial. The goal was to see if oxytocin makes group therapy more effective by improving social connection and reducing stress.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA SPECTRUM DISORDERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Charité Universitätsmedizin Berlin, Campus Benjamin Franklin

    Berlin, State of Berlin, 12203, Germany

Conditions

Explore the condition pages connected to this study.